Lin Li

11.7k total citations · 2 hit papers
145 papers, 5.9k citations indexed

About

Lin Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lin Li has authored 145 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 57 papers in Cancer Research and 48 papers in Oncology. Recurrent topics in Lin Li's work include Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (16 papers) and RNA modifications and cancer (13 papers). Lin Li is often cited by papers focused on Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (16 papers) and RNA modifications and cancer (13 papers). Lin Li collaborates with scholars based in China, United States and United Kingdom. Lin Li's co-authors include Warner C. Greene, Wangjun Liao, George Demartino, Junfang Xu, Sheng Xu, Zhengping Jiang, Yanmei Han, Pin Wang, Cong Wu and Qiuyan Liu and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lin Li

135 papers receiving 5.8k citations

Hit Papers

The STAT3-Binding Long Noncoding RNA lnc-DC Controls Huma... 2014 2026 2018 2022 2014 2021 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Li China 39 3.3k 2.8k 1.3k 814 620 145 5.9k
Lin Feng China 44 3.2k 1.0× 1.1k 0.4× 1.0k 0.8× 614 0.8× 369 0.6× 184 5.5k
Jie Xu China 48 4.6k 1.4× 2.3k 0.8× 1.3k 1.0× 667 0.8× 460 0.7× 214 7.2k
En‐Min Li China 42 4.0k 1.2× 1.7k 0.6× 1.1k 0.8× 590 0.7× 835 1.3× 293 6.2k
Ding Ma China 37 2.8k 0.9× 1.9k 0.7× 1.7k 1.3× 771 0.9× 1.0k 1.6× 202 5.7k
Liu Hong China 40 3.3k 1.0× 1.9k 0.7× 1.1k 0.8× 556 0.7× 715 1.2× 251 5.8k
Eiso Hiyama Japan 41 4.0k 1.2× 1.3k 0.5× 1.8k 1.4× 584 0.7× 800 1.3× 230 8.8k
Dan Ye China 37 2.8k 0.8× 1.3k 0.5× 556 0.4× 744 0.9× 341 0.6× 148 5.2k
Jacqueline Cloos Netherlands 46 5.1k 1.5× 1.6k 0.6× 1.9k 1.5× 569 0.7× 486 0.8× 203 8.7k
Lijuan Wang China 36 2.6k 0.8× 1.9k 0.7× 968 0.7× 372 0.5× 344 0.6× 146 4.4k
Rui Zhang China 49 5.9k 1.8× 4.1k 1.5× 972 0.7× 672 0.8× 681 1.1× 290 7.8k

Countries citing papers authored by Lin Li

Since Specialization
Citations

This map shows the geographic impact of Lin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Li more than expected).

Fields of papers citing papers by Lin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Li. The network helps show where Lin Li may publish in the future.

Co-authorship network of co-authors of Lin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Li. A scholar is included among the top collaborators of Lin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Li. Lin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Xuefeng, Su Zhang, Min Ou, et al.. (2025). Berbamine promotes autophagy and GPX4 expression through inducing abundant ROS to restrict HIV-1 and Mtb coinfection in macrophages. Journal of Leukocyte Biology. 117(7).
3.
Bansod, Sapana, Peng Liu, Lin Li, et al.. (2024). The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS. Cell Reports. 43(9). 114667–114667. 1 indexed citations
5.
Yao, Zhen, et al.. (2024). 16P Homologous recombination deficiency in endometrial cancer: Association with clinical and molecular characteristics. ESMO Open. 9. 103516–103516. 1 indexed citations
6.
Hu, Xingbin, Shulong Li, Zhiqi Yao, et al.. (2023). Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2‐positive gastric cancer. Cancer Communications. 43(8). 909–937. 61 indexed citations
7.
Ruan, Jian, et al.. (2023). Safety and feasibility of intra-arterial delivery of teniposide to high grade gliomas after blood–brain barrier disruption: a case series. Journal of NeuroInterventional Surgery. 16(11). 1152–1156. 5 indexed citations
9.
Liang, Boxuan, Yizhou Zhong, Yuji Huang, et al.. (2021). Underestimated health risks: polystyrene micro- and nanoplastics jointly induce intestinal barrier dysfunction by ROS-mediated epithelial cell apoptosis. Particle and Fibre Toxicology. 18(1). 20–20. 331 indexed citations breakdown →
10.
Tan, Yue, Kui He, Bing Tang, et al.. (2020). Precisely Regulated Luminescent Gold Nanoparticles for Identification of Cancer Metastases. ACS Nano. 14(10). 13975–13985. 34 indexed citations
11.
12.
Li, Lin, Hulai Wei, Juan Yi, et al.. (2019). Chronic CagA‐positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell‐like properties in gastric mucosal epithelial cells. Journal of Cellular Biochemistry. 120(10). 17635–17649. 27 indexed citations
13.
Jiang, Hongmei, Ming Xu, Lin Li, et al.. (2018). Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Molecular Cancer Therapeutics. 17(10). 2144–2155. 32 indexed citations
14.
Pan, Xiaoyan, Xinfeng Xu, Jian Lin, et al.. (2017). Resveratrol Reactivates Latent HIV through Increasing Histone Acetylation and Activating Heat Shock Factor 1. Journal of Agricultural and Food Chemistry. 65(22). 4384–4394. 25 indexed citations
15.
Li, Duan, et al.. (2017). Variant in GALNT3 Gene Linked with Reduced Coronary Artery Disease Risk in Chinese Population. DNA and Cell Biology. 36(7). 529–534. 1 indexed citations
16.
Zhang, Daoxiang, Lin Li, Hongmei Jiang, et al.. (2016). Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 23(7). 1748–1759. 60 indexed citations
17.
Li, Lin, Na Xu, Jinfang Zhang, et al.. (2016). EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins. International Journal of Medical Sciences. 13(5). 365–373. 8 indexed citations
18.
Wang, Pin, Yiquan Xue, Yanmei Han, et al.. (2014). The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation. Science. 344(6181). 310–313. 884 indexed citations breakdown →
19.
Wang, Lin, Yajun Wu, Lin Li, et al.. (2013). Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. International Journal of Cancer. 133(6). 1419–1430. 98 indexed citations
20.
Ke, Menglin, et al.. (2012). PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in China. Value in Health. 15(7). A637–A638. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026